Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemo-Cemiplimab for Stage I NSCLC
NCT07720167Phase 2Not yet recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of cemiplimab in non-small cell lung cancer (NSCLC), sponsored by Medical University of South Carolina. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
cemiplimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07720167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720167.